Please use this identifier to cite or link to this item:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/89821Full metadata record
| ???org.dspace.app.webui.jsptag.ItemTag.dcfield??? | Value | Language |
|---|---|---|
| dc.contributor.advisor | 王根樹 | zh_TW |
| dc.contributor.advisor | Gen-Shuh Wang | en |
| dc.contributor.author | 余姿蓉 | zh_TW |
| dc.contributor.author | Zih-Rong Yu | en |
| dc.date.accessioned | 2023-09-22T16:15:49Z | - |
| dc.date.available | 2023-11-09 | - |
| dc.date.copyright | 2023-09-22 | - |
| dc.date.issued | 2023 | - |
| dc.date.submitted | 2023-08-09 | - |
| dc.identifier.citation | 黃諭憑（2022）。以兩種高級氧化處理程序移除醫院廢水中藥品及個人保健品。﹝碩士論文。國立臺灣大學﹞臺灣博碩士論文知識加值系統。
Al aukidy, M., Verlicchi, P., Jelic, A., Petrovic, M., & Barcelò, D. (2012). Monitoring Release of Pharmaceutical Compounds: Occurrence and Environmental Risk Assessment of Two WWTP Effluents and Their Receiving Bodies in the Po Valley, Italy. Science of The Total Environment, 438, 15–25. doi: https://doi.org/10.1016/j.scitotenv.2012.08.061 Al-Maadheed, S., Goktepe, I., Latiff, A. B. A., & Shomar, B. (2019). Antibiotics in Hospital Effluent and Domestic Wastewater Treatment Plants in Doha, Qatar. Journal of Water Process Engineering, 28, 60–68. Doi: https://doi.org/https://doi.org/10.1016/j.jwpe.2019.01.005 Al-Qaim, F. F., Abdullah, M. P., Othman, M. R., Latip, J., & Zakaria, Z. (2014). Multi-Residue Analytical Methodology-Based Liquid Chromatography-Time-of-Flight-Mass Spectrometry for the Analysis of Pharmaceutical Residues in Surface Water and Effluents from Sewage Treatment Plants and Hospitals. Journal of Chromatography A, 1345, 139–153. doi: https://doi.org/10.1016/j.chroma.2014.04.025 Bautitz, I. R., & Nogueira, R. F. P. (2010). Photodegradation of Lincomycin and Diazepam in Sewage Treatment Plant Effluent by Photo-Fenton Process. Catalysis Today, 151(1–2), 94–99. Doi: https://doi.org/10.1016/j.cattod.2010.02.018 Becker, R. W., Ibáñez, M., Lumbaque, E. C., Wilde, M. L., Rosa, T. F. da, Hernández, F., & Sirtori, C. (2020). Investigation of Pharmaceuticals and Their Metabolites in Brazilian Hospital Wastewater by LC-QTOF MS Screening Combined with a Preliminary Exposure and in Silico Risk Assessment. Science of The Total Environment, 699, 134218. Doi: https://doi.org/https://doi.org/10.1016/j.scitotenv.2019.134218 Benner, J., & Ternes, T. A. (2009). Ozonation of Propranolol: Formation of Oxidation Products. Environmental Science & Technology, 43(13), 5086–5093. Doi: https://doi.org/10.1021/es900282c Biel-maeso, M., Corada-fernández, C., & Lara-martín, P. A. (2018). Monitoring the Occurrence of Pharmaceuticals in Soils Irrigated with Reclaimed Wastewater. Environmental Pollution, 235, 312–321. Doi: https://doi.org/10.1016/j.envpol.2017.12.085 Boal, A.K., Rhodes, C. and Garcia, S. (2015) Pump-and-treat groundwater remediation using chlorine/ultraviolet advanced oxidation processes. Groundwater Monitoring and Remediation, 35(2), 93– 100. Doi: https://doi.org/10.1111/gwmr.12095. Bu, Q. (2013). Pharmaceuticals and Personal Care Products in the Aquatic Environment in China: A Review. Journal of Hazardous Materials, 262, 189–211. doi: https://doi.org/10.1016/j.jhazmat.2013.08.040 Camacho-Muñoz, D., Martín, J., Santos, J.L. (2012). Effectiveness of Conventional and Low-Cost Wastewater Treatments in the Removal of Pharmaceutically Active Compounds. Water Air Soil Pollut 223, 2611–2621. doi: https://doi.org/10.1007/s11270-011-1053-9 Carbajo, J. B., Petre, A. L., Rosal, R., Herrera, S., Letón, P., García-calvo, E., fernández-alba, A. R., & Perdigón-melón, J. A. (2015). Continuous Ozonation Treatment of Ofloxacin: Transformation Products, Water Matrix Effect and Aquatic Toxicity. Journal of Hazardous Materials, 292, 34–43. Doi: https://doi.org/https://doi.org/10.1016/j.jhazmat.2015.02.075 Chien, H., Ko, J., Chen, Y., Weng, S., Yang, W., Chang, Y., & Liu, H. (2013). Study of Medication Waste in Taiwan. Journal of Experimental & Clinical Medicine, 5(2), 69–72. doi: https://doi.org/10.1016/j.jecm.2013.02.003 Chen, H., Wang, P., & Ding, W. (2008). Using Liquid Chromatography–Ion Trap Mass Spectrometry to Determine Pharmaceutical Residues in Taiwanese Rivers and Wastewaters. Chemosphere, 72(6), 863–869. doi: https://doi.org/10.1016/j.chemosphere.2008.04.005 De la cruz, N., Giménez, J., Esplugas, S., Grandjean, D., De alencastro, L. F., & Pulgarín, C. (2012). Degradation of 32 Emergent Contaminants by UV and Neutral Photo-Fenton in Domestic Wastewater Effluent Previously Treated by Activated Sludge. Water Research, 46(6), 1947–1957. Doi: https://doi.org/10.1016/j.watres.2012.01.014 Fast, S. A., Gude, V. G., Truax, D. D., Martin, J., & Magbanua, B. S. (2017). A Critical Evaluation of Advanced Oxidation Processes for Emerging Contaminants Removal. Environ. Process., 4(1), 283–302. Doi: https://doi.org/https://doi.org/10.1007/s40710-017-0207-1 Ghanbari, F., Yaghoot-nezhad, A., Wacławek, S., Lin, K. A., Rodríguez-chueca, J., & Mehdipour, F. (2021). Comparative Investigation of Acetaminophen Degradation in Aqueous Solution by UV/Chlorine and UV/H2O2 Processes: Kinetics and Toxicity Assessment, Process Feasibility and Products Identification. Chemosphere, 285, 131455. Doi: https://doi.org/https://doi.org/10.1016/j.chemosphere.2021.131455 Gómez, M. J., Petrović, M., Fernández-alba, A. R., & Barceló, D. (2005). Determination of Pharmaceuticals of Various Therapeutic Classes by Solid-Phase Extraction and Liquid Chromatography–Tandem Mass Spectrometry Analysis in Hospital Effluent Wastewaters. Journal of Chromatography A, 1114(2), 224–233. doi: https://doi.org/10.1016/j.chroma.2006.02.038 Gros, M., Petrović, M., & Barceló, D. (2006). Development of a Multi-Residue Analytical Methodology Based on Liquid Chromatography–Tandem Mass Spectrometry (LC–MS/MS) for Screening and Trace Level Determination of Pharmaceuticals in Surface and Wastewaters. Talanta, 70(4), 678–690. Doi: https://doi.org/10.1016/j.talanta.2006.05.024 Guo, K., Wu, Z., Shang, C., Yao, B., Hou, S., Yang, X., Song, W., & Fang, J. (2017). Radical Chemistry and Structural Relationships of PPCP Degradation by UV/Chlorine Treatment in Simulated Drinking Water. Environmental Science & Technology, 51(18), 10431–10439. doi: 10.1021/acs.est.7b02059 Heberer, T. (2002). Occurrence, Fate, and Removal of Pharmaceutical Residues in the Aquatic Environment: A Review of Recent Research Data. Toxicology Letters, 131(1–2), 5–17. doi: https://doi.org/10.1016/S0378-4274(02)00041-3 Hernando, M. D., Petrovic, M., fernandez-alba, A. R., & Barceló , D. (2004). Analysis by Liquid Chromatography–Electrospray Ionization Tandem Mass Spectrometry and Acute Toxicity Evaluation for β-Blockers and Lipid-Regulating Agents in Wastewater Samples☆. Journal of Chromatography A, 1046(1–2), 133–140. doi: https://doi.org/10.1016/j.chroma.2004.06.102 Jiang, X., Qu, Y., Liu, liquan, He, Y., Li, W., Huang, J., Yang, H., & Yu, G. (2020). PPCPs in a Drinking Water Treatment Plant in the Yangtze River Delta of China: Occurrence, Removal and Risk Assessment. Frontiers of Environmental Science & Engineering, 13, 27. doi: https://doi.org/10.1007/s11783-019-1109-4 Khan, M. T., Shah, I. A., Ihsanullah, I., Naushad, Mu., Ali, S., Shah, S. H. A., & Mohammad, A. W. (2021). Hospital Wastewater as a Source of Environmental Contamination: An Overview of Management Practices, Environmental Risks, and Treatment Processes. Journal of Water Process Engineering, 41, 101990. Doi: https://doi.org/https://doi.org/10.1016/j.jwpe.2021.101990 Khetan, S. K., & Collins, T. J. (2007). Human Pharmaceuticals in the Aquatic Environment: A Challenge to Green Chemistry. Chemical Reviews, 107(6), 2319–2364. doi: https://doi.org/10.1021/cr020441w Kim, I., Yamashita, N., & Tanaka, H. (2009). Performance of UV and UV/H2O2 Processes for the Removal of Pharmaceuticals Detected in Secondary Effluent of a Sewage Treatment Plant in Japan. Journal of Hazardous Materials, 166(2–3), 1134–1140. Doi: https://doi.org/10.1016/j.jhazmat.2008.12.020 Klamerth, N., Rizzo, L., Malato, S., Maldonado, M. I., Agüera, A., & Fernández-alba, A. R. (2010). Degradation of Fifteen Emerging Contaminants at ΜgL−1 Initial Concentrations by Mild Solar Photo-Fenton in MWTP Effluents. Water Research, 44(2), 545–554. Doi: https://doi.org/10.1016/j.watres.2009.09.059 Lin, A. Y., & Tsai, Y. (2009). Occurrence of Pharmaceuticals in Taiwan’s Surface Waters: Impact of Waste Streams from Hospitals and Pharmaceutical Production Facilities. Science of The Total Environment, 407(12), 3793–3802. Doi: https://doi.org/https://doi.org/10.1016/j.scitotenv.2009.03.009 Li, W., Nanaboina, V., Zhou, Q., & Korshin, G. V. (2012). Effects of Fenton Treatment on the Properties of Effluent Organic Matter and Their Relationships with the Degradation of Pharmaceuticals and Personal Care Products. Water Research, 46(2), 403–412. Doi: https://doi.org/10.1016/j.watres.2011.11.002 Markiewicz, M., Jungnickel, C., Stolte, S., Białk-bielińska, A., Kumirska, J., & Mrozik, W. (2017). Primary Degradation of Antidiabetic Drugs. Journal of Hazardous Materials, 324(Part B), 428–435. doi: https://doi.org/10.1016/j.jhazmat.2016.11.008 Martín, J., Camacho-muñoz, D., L. santos, J., Aparicio, I., & Alonso, E. (2012). Occurrence of Pharmaceutical Compounds in Wastewater and Sludge from Wastewater Treatment Plants: Removal and Ecotoxicological Impact of Wastewater Discharges and Sludge Disposal. Journal of Hazardous Materials, 239–240, 40–47. doi: https://doi.org/10.1016/j.jhazmat.2012.04.068 Michael, I., Hapeshi, E., Michael, C., & Fatta-kassinos, D. (2010). Solar Fenton and Solar TiO2 Catalytic Treatment of Ofloxacin in Secondary Treated Effluents: Evaluation of Operational and Kinetic Parameters. Water Research, 44(18), 5450–5462. doi: https://doi.org/10.1016/j.watres.2010.06.053 Mohapatra, D. P., Brar, S. K., Tyagi, R. D., Picard, P., & Surampalli, R. Y. (2013). A Comparative Study of Ultrasonication, Fenton’s Oxidation and Ferro-Sonication Treatment for Degradation of Carbamazepine from Wastewater and Toxicity Test by Yeast Estrogen Screen (YES) Assay. Science of The Total Environment, 447, 280–285. Doi: https://doi.org/10.1016/j.scitotenv.2012.12.072 Munch, D. J., & Hautman, D. P. (1994). Method 551.1: Determination of Chlorination Disinfection Byproducts, Chlorinated Solvents, and Halogenated Pesticides/Herbicides in Drinking Water by Liquid-Liquid Extraction and Gas Chromatography with Electron-Capture Detection. Methods for the Determination of Organic Compounds in Drinking Water. Ngumba, E., Gachanja, A., & Tuhkanen, T. (2020). Removal of Selected Antibiotics and Antiretroviral Drugs during Post-Treatment of Municipal Wastewater with UV, UV/Chlorine and UV/Hydrogen Peroxide. Water and Environment Journal, 34(4), 692–703. Doi: https://doi.org/https://doi.org/10.1111/wej.12612 Pai, C., & Wang, G. (2022). Treatment of PPCPs and Disinfection By-Product Formation in Drinking Water through Advanced Oxidation Processes: Comparison of UV, UV/Chlorine, and UV/H2O2. Chemosphere, 287(Part 3), 132171. Doi: https://doi.org/https://doi.org/10.1016/j.chemosphere.2021.132171 Pan, Y., Li, X., Fu, K., Gu, Z., Shi, J., & Deng, H. (2020). Overlooked Role of Secondary Radicals in the Degradation of Beta-Blockers and Toxicity Change in UV/Chlorine Process. Chemical Engineering Journal, 391, 123606. Doi: https://doi.org/https://doi.org/10.1016/j.cej.2019.123606 Rosal, R., Rodea-Palomares, I., Boltes, K. et al. Ecotoxicity assessment of lipid regulators in water and biologically treated wastewater using three aquatic organisms. Environ Sci Pollut Res 17, 135–144 (2010). doi: https://doi.org/10.1007/s11356-009-0137-1 Sarkar, A., Tiwari, A., Bhasin, P. S., & Mitra, M. (2011). Pharmacological and pharmaceutical profile of gliclazide: a review. Journal of Applied Pharmaceutical Science, 01(09), 11-19. doi: https://japsonline.com/admin/php/uploads/253_pdf.pdf Shokoohi, R., Ghobadi, N., Godini, K., Hadi, M., & Atashzaban, Z. (2020). Antibiotic Detection in a Hospital Wastewater and Comparison of Their Removal Rate by Activated Sludge and Earthworm-Based Vermifilteration: Environmental Risk Assessment. Process Safety and Environmental Protection, 134, 169–177. Doi: https://doi.org/https://doi.org/10.1016/j.psep.2019.10.020 Ternes, T. A. (1998). Occurrence of Drugs in German Sewage Treatment Plants and Rivers. Water Research, 32(11), 3254–3260. Doi: https://doi.org/10.1016/S0043-1354(98)00099-2 Tiago S. O., Murphy, M., Mendola, N., Wong, V., Carlson, D., & Waring, L. (2015). Characterization of Pharmaceuticals and Personal Care Products in Hospital Effluent and Waste Water Influent/Effluent by Direct-Injection LC-MS-MS. Science of The Total Environment, 518–519, 459–478. doi: https://doi.org/10.1016/j.scitotenv.2015.02.104 Trovó, A. G., Melo, S. A. S., & Nogueira, R. F. P. (2008). Photodegradation of the Pharmaceuticals Amoxicillin, Bezafibrate and Paracetamol by the Photo-Fenton Process—Application to Sewage Treatment Plant Effluent. Journal of Photochemistry and Photobiology A: Chemistry, 198(2–3), 215–220. Doi: https://doi.org/10.1016/j.jphotochem.2008.03.011 Ulvi, A., Aydın, S. & Aydın, M.E. Fate of selected pharmaceuticals in hospital and municipal wastewater effluent: occurrence, removal, and environmental risk assessment. Environ Sci Pollut Res 29, 75609–75625 (2022). doi: https://doi.org/10.1007/s11356-022-21131-y Vasconcelos, T. G., Kümmerer, K., Henriques, D. M., & Martins, A. F. (2009). Ciprofloxacin in Hospital Effluent: Degradation by Ozone and Photoprocesses. Journal of Hazardous Materials, 169(1–3), 1154–1158. Doi: https://doi.org/https://doi.org/10.1016/j.jhazmat.2009.03.143 Verlicchi, P., Al aukidy, M., & Zambello, E. (2012). Occurrence of Pharmaceutical Compounds in Urban Wastewater: Removal, Mass Load and Environmental Risk after a Secondary Treatment—A Review. Science of The Total Environment, 429, 123–155. doi: https://doi.org/10.1016/j.scitotenv.2012.04.028 Wang, J., & Wang, S. (2016). Removal of Pharmaceuticals and Personal Care Products (PPCPs) from Wastewater: A Review. Journal of Environmental Management, 182, 620–640. Doi: https://doi.org/https://doi.org/10.1016/j.jenvman.2016.07.049 Wilde, M. l., Montipó, sheila, & Martins, A. f. (2014). Degradation of β-Blockers in Hospital Wastewater by Means of Ozonation and Fe2+/Ozonation. Water Research, 48, 280–295. doi: https://doi.org/10.1016/j.watres.2013.09.039 Yang, Y., Ok, Y. sik, Kim, K., Kwon, E. e., & Tsang, Y. fai. (2017). Occurrences and Removal of Pharmaceuticals and Personal Care Products (PPCPs) in Drinking Water and Water/Sewage Treatment Plants: A Review. Science of The Total Environment, 596–597, 303–320. doi: https://doi.org/10.1016/j.scitotenv.2017.04.102 Yang, X., Sun, J., Fu, W., Shang, C., Chen, Y., Gan, W., & Fang, J. (2016). PPCP Degradation by UV/Chlorine Treatment and Its Impact on DBP Formation Potential in Real Waters. Water Research, 98, 309–318. doi: https://doi.org/10.1016/j.watres.2016.04.011 Yeom, Y., Han, J., Zhang, X., Shang, C., Zhang, T., Li, X., Duan, X., & Dionysiou, D. D. (2021). A Review on the Degradation Efficiency, DBP Formation, and Toxicity Variation in the UV/Chlorine Treatment of Micropollutants. Chemical Engineering Journal, 424(130053). doi: https://doi.org/10.1016/j.cej.2021.130053 | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/89821 | - |
| dc.description.abstract | 水是生活中不可或缺的資源，但在現今，水資源的獲取變得越來越困難。由於台灣地形狹長且人口密集等原因，水資源的獲得及保存變得困難，而單一個人可使用的水資源亦相對匱乏。此外，使用過的廢污水經處理後再次排放到環境水體中，其中的污染物可能對環境生態造成影響。
水處理的過程可分為自來水處理和廢水處理，這些處理程序的主要目標是確保水質的安全性。除了常規的水質監測外，隨著檢測技術和儀器的進步，新興的污染物也開始在不同的水體中被檢測到。藥物及個人防護產品(PPCPs)是新興污染物的一環，其流佈與人為活動有關。台灣目前已邁入高齡化社會，隨之而來是逐漸盛行的慢性病問題。高血壓、高血脂、高血糖則是台灣最廣為認知的三大慢性病，三者俗稱為「三高」，一直是大眾所關注的議題。而治療三高所需的三高用藥也在台灣被廣泛使用，根據健保署藥物使用資料，這些藥物近年被大量使用，並可能在水體中被檢測出來。這些藥物包含治療高血壓的beta-blockers類藥物(atenolol, metoprolol, propranolol)、治療高血脂的fibrates類藥物(bezafibrate, gemfibrozil, fenofibrate)以及治療高血糖的gliclazide。 傳統的廢水處理方法對於移除民生廢水或醫院廢水中PPCPs的效率並不一致。本研究的目的在調查醫院廢水中三高用藥的濃度，使用UV/Chlorine處理方式了解高級氧化處理的去除效率，並比較傳統處理與高級氧化處理(UV/Chlorine)對三高用藥的移除效率。 此研究調查了三間醫院沸水中的三高用藥。研究結果顯示，醫院廢水處理廠原廢水、二級處理水和放流水中，原廢水中的藥物濃度最高，並可在原廢水中測出Atenolol、Metoprolol、Propranolol、Bezafibrate、Gemfibrozil、Fenofibrate和Gliclazide這七種藥物。透過一級和二級處理後，大多數的三高用藥皆有降解，而降解百分比根據原廢水及二級處理水中濃度介於至-900%至100%，但大多數藥物在二次處理水仍可以被檢出。而在二級處理水與加氯消毒後放流水的濃度比較中，兩者濃度並無太大差異。將二級處理水進行高級氧化處理，降解污染物，可觀察到加氯的濃度以及照UV光的反應時間會影響三高用藥的降解效率。並且在此研究的實驗中，氯在UV/Chlorine處理的反應終點幾乎耗盡。在消毒副產物的生成上，發現THMs、HAAs、HANs等消毒副產物濃度有少量增加，但與單純加氯相較並無太大差異。 隨著加氯的濃度增加以及反應時間增加，PPCPs移除的效率也隨之增加。在醫院廢水中，經過UV/Chlorine處理的三高用藥與未處理前比較下，降解率介於14%至99%之間。這其中beta-blockers類和gliclazide降解效率較好，fibrates類之降解效率相對較低。不同間醫院廢水間，因為有機污染物濃度以及起始pH值不同，其降解效率也有很大的差異。 | zh_TW |
| dc.description.abstract | Water is an essential resource, but access to water is becoming increasingly difficult. Because of Taiwan's long and narrow terrain and dense population, it is challenging to preserve water resources, and the water resources that a single person can use are relatively scarce. Moreover, the used wastewater will be discharged into the receiving environmental water after treatment, and the contaminants in the effluent may affect the environmental ecology and human health.
Water treatment can be divided into drinking water treatment and wastewater treatment. In addition to general water quality monitoring, emerging contaminants have begun to be detected in different water bodies with the improvements of analytical technologies and instruments. Among the pharmaceutical and personal care products (PPCPs), hypertension, hyperlipidemia, and diabetes are common chronic diseases in the elderly in Taiwan, and the corresponding amount of therapeutic drugs used are also considerable when compared with other medicines prescribed. In this study, seven commonly used medicines for these diseases, including beta-blockers (atenolol, metoprolol, propranolol), fibrates (bezafibrate, gemfibrozil, fenofibrate), and gliclazide were assessed for their presences and removals in hospital wastewater; these medicines have been used in high amounts in Taiwan and may cause potential health hazards when presented in environmental waters, such as bezafibrate may induce the proliferation of peroxisomes in rodent livers. To effectively remove PPCPs, advanced oxidation processes (AOPs) are classified as available treatment technology for PPCPs. AOPs have been shown effective for degrading refractory organic contaminants, reducing disinfection by-product formation, rapid reaction rates, and promoting water reuses. This study determined the concentrations of three-hypers series medicine in three hospital wastewater, the PPCPs removal efficiencies after conventional wastewater treatments were assessed, and UV/chlorine process was adopted to assess its ability to remove PPCPs from hospital wastewater. The results of the study showed that, among the three investigated hospital wastewater samples (raw wastewater, secondary treatment water, and effluents), the PPCP concentration in the raw wastewater was the highest, and atenolol, metoprolol, propranolol, bezafibrate, gemfibrozil, fenofibrate, and gliclazide could be detected in the raw wastewater. After primary and secondary treatment, most of the three-hypers series medicine are degraded, and the percentage degradation was -900% to 100% according to the PPCP concentrations of the raw wastewater and the post secondary treatment water. However, most of the PPCPs were still left in the post secondary treatment water. In comparing the concentration of the secondary treated water and the effluents after chlorination, there was not apparent difference between their concentrations. The post secondary treatment water was subjected to an advanced oxidation treatment to degrade contaminants. It can be observed that the concentration of chlorine and the reaction time of UV irradiation will affect the degradation efficiency of the three high drugs. Moreover, in this study, the chlorine was almost consumed at the end of the reaction. In terms of the generation of disinfection by-products (DBPs), it was found that THMs, HAAs, and HANs increased slightly, but there was no significant difference when compared to the DBPs after simple chlorination. As the concentration of chlorine added and the reaction time increased, the removal efficiency also increased. In hospital wastewater, the degradation rate of the UV/Chlorine-treated three-high drug was between 14 % and 100 % when compared with that before treatment. Most of the beta-blockers and gliclazide can be thoroughly degraded, and the degradation efficiency for fibrates were relatively low in. The degradation efficiency of wastewater from different hospitals varies significantly due to the different concentrations of organic pollutants and initial pH. | en |
| dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2023-09-22T16:15:49Z No. of bitstreams: 0 | en |
| dc.description.provenance | Made available in DSpace on 2023-09-22T16:15:49Z (GMT). No. of bitstreams: 0 | en |
| dc.description.tableofcontents | 謝辭 i
中文摘要 ii Contents vii List of Figures ix List of Tables xiii Chapter 1 Introduction 1 1.1 Background 1 1.2 Objective of This Study 2 Chapter 2 Literature review 4 2.1 Uses of Pharmaceuticals and personal care products 4 2.1.1 Selected PPCPs in this study 5 2.1.2 PPCPs in hospital wastewater 9 2.2 Overview of AOPs in water and wastewater treatments 11 2.2.1 AOP applications in water and wastewater treatment 11 2.2.2 UV/Chlorine 14 Chapter 3 Materials and Methods 17 3.1 Research framework 17 3.2 Sample collections 19 3.3 Pharmaceuticals and personal care products (PPCPs) analysis 19 1. Beta-blockers group 20 2. Fibrates group 20 3. Gliclazide 21 3.4 Advanced oxidation processes 21 3.4.1 Equipment of advanced oxidation processes 21 3.4.2 Procedures of advanced oxidation processes 22 3.5 Sample analysis 22 Chapter 4 Results and discussion 25 4.1 Water quality parameters of the treated hospital wastewater samples 25 4.2 PPCP determinations in different water matrix 28 4.2.1 Solid phase extraction (SPE) 28 4.2.2 Method validation 29 4.2.3 PPCP determinations for wastewater collected from hospital 33 4.2.4 Chlorine concentration changes in UV/Chlorine treatment 38 4.3 Removal of PPCPs in UV/Chlorine process 40 4.3.1 Results of laboratory bench-scale simulation 40 4.3.2 UV/Chlorine treatment with hospital wastewaters 44 4.3.3 Changes of NPDOC in hospital wastewater after AOPs treatment 52 4.3.4 Chlorine concentration changes after UV/Chlorine treatment with hospital wastewater 54 4.3.5 Formation of DBPs in the UV/Chlorine process 56 4.3.6 Comparing the removal efficiency of PPCPs between hospital wastewater treatment and UV/Chlorine treatments 63 Chapter 5 Conclusions and suggestions 66 List of Abbreviations 68 References 69 Appendices 75 | - |
| dc.language.iso | en | - |
| dc.subject | 醫院廢水 | zh_TW |
| dc.subject | UV/Chlorine | zh_TW |
| dc.subject | 高級氧化 | zh_TW |
| dc.subject | 藥物及個人防護產品 | zh_TW |
| dc.subject | 三高用藥 | zh_TW |
| dc.subject | advanced oxidation processes (AOPs) | en |
| dc.subject | pharmaceuticals and personal care products (PPCPs) | en |
| dc.subject | three-hyper series medicine | en |
| dc.subject | hospital wastewater | en |
| dc.subject | UV/Chlorine | en |
| dc.title | 醫院廢水中三高用藥調查及以UV/Chlorine程序移除之研究 | zh_TW |
| dc.title | Detections of Three-Hypers Series Medicine in Hospital Wastewater and Their Removals with UV/Chlorine Processes | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 111-2 | - |
| dc.description.degree | 碩士 | - |
| dc.contributor.oralexamcommittee | 蔡詩偉;童心欣;林財富 | zh_TW |
| dc.contributor.oralexamcommittee | Shih-Wei Tsai;Hsin-Hsin Tung;Tsair-Fuh Lin | en |
| dc.subject.keyword | 醫院廢水,高級氧化,UV/Chlorine,藥物及個人防護產品,三高用藥, | zh_TW |
| dc.subject.keyword | hospital wastewater,advanced oxidation processes (AOPs),pharmaceuticals and personal care products (PPCPs),three-hyper series medicine,UV/Chlorine, | en |
| dc.relation.page | 97 | - |
| dc.identifier.doi | 10.6342/NTU202303773 | - |
| dc.rights.note | 同意授權(限校園內公開) | - |
| dc.date.accepted | 2023-08-09 | - |
| dc.contributor.author-college | 公共衛生學院 | - |
| dc.contributor.author-dept | 環境與職業健康科學研究所 | - |
| Appears in Collections: | 環境與職業健康科學研究所 | |
Files in This Item:
| File | Size | Format | |
|---|---|---|---|
| ntu-111-2.pdf Access limited in NTU ip range | 2.85 MB | Adobe PDF |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.